AUSTRALIAN DRUG DEVELOPMENT BLOG
The Latest Blogs from Agilex Biolabs

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO In the high-stakes world of drug development, biotech companies face unique challenges at every stage -...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Liquid chromatography-mass spectrometry (LCMS) has become an indispensable tool for the pharmaceutical a...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Preclinical toxicology studies are an essential part of the drug development process as they provide ins...

Author By Agilex Biolabs发布日期
By Dr. Kurt Sales, CSO Biomarkers are playing an increasingly important role in clinical studies where they can provide essenti...

Author By Agilex Biolabs发布日期
by Dr. Kurt Sales, Chief Scientific Officer Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been the preferred an...

Author By Agilex Biolabs发布日期
An exclusive delegation coming from Australia - where leading drug development experts will converge. The Agilex team would lik...

Author By Agilex Biolabs发布日期
Flow cytometry has become a powerful tool in the bioanalytical arsenal. In an era where pharmaceuticals are becoming more targe...

Author By Agilex Biolabs发布日期
Agilex 为客户提供小分子解决方案,帮助他们取得成功。Agilex Biolabs 正在庆祝其成立 29 周年...

Author By Agilex Biolabs发布日期
30 年来,Agilex 一直为生物技术公司提供中枢神经系统靶向药物。近 30 年来,Agilex Biolabs 一直为生物技术公司提供中枢神经系统靶向药物。

Author By Agilex Biolabs发布日期
面对现实吧--全世界的人口都在老龄化。我们越来越多地看到这些神经系统疾病的增长...

Author By Agilex Biolabs发布日期
在分子生物学和药理学中,小分子因其快速调节作用的能力而备受关注。这是因为...

Author By Agilex Biolabs发布日期
应用数十年经验,着眼于小分子药物开发的未来 在抗体药物问世之前的数十年里,我们一直在研究小分子药物开发的未来。